These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15545283)

  • 1. Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation.
    Li CY; Zhu J; Wang JY
    J Biol Chem; 2005 Jan; 280(3):2159-64. PubMed ID: 15545283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells.
    Nyman U; Sobczak-Pluta A; Vlachos P; Perlmann T; Zhivotovsky B; Joseph B
    J Biol Chem; 2005 Oct; 280(40):34159-69. PubMed ID: 16087678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
    Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
    Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
    Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
    Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
    Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
    Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
    Di Como CJ; Gaiddon C; Prives C
    Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.
    Xu ZH; Zhao MJ; Li TP
    World J Gastroenterol; 2002 Dec; 8(6):1094-7. PubMed ID: 12439932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity.
    Takagi S; Ueda Y; Hijikata M; Shimotohno K
    FEBS Lett; 2001 Nov; 509(1):47-52. PubMed ID: 11734204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell density-dependent regulation of p73 in breast cancer cells.
    Tophkhane C; Yang S; Zhao ZJ; Yang X
    Int J Oncol; 2009 Dec; 35(6):1429-34. PubMed ID: 19885566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P73 C-terminus is dispensable for multiciliogenesis.
    Buckley N; Panatta E; Morone N; Noguchi M; Scorrano L; Knight RA; Amelio I; Melino G
    Cell Cycle; 2020 Jul; 19(14):1833-1845. PubMed ID: 32584647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relief of p53-mediated telomerase suppression by p73.
    Toh WH; Kyo S; Sabapathy K
    J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
    Minty A; Dumont X; Kaghad M; Caput D
    J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIP60 represses transcriptional activity of p73beta via an MDM2-bridged ternary complex.
    Kim JW; Song PI; Jeong MH; An JH; Lee SY; Jang SM; Song KH; Armstrong CA; Choi KH
    J Biol Chem; 2008 Jul; 283(29):20077-86. PubMed ID: 18499675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
    Miro-Mur F; Meiller A; Haddada H; May E
    Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm.
    Kim EJ; Park JS; Um SJ
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1101-6. PubMed ID: 17825253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
    Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
    Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.